Serum KL-6 levels in lung cancer patient
β
Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroich
π
Article
π
2010
π
John Wiley and Sons
π
English
β 90 KB
## Abstract __Background__: It is not known whether lung cancer patients with interstitial lung disease (ILD) might have higher serum levels of KLβ6, a high molecular weight glycoprotein classified as a polymorphic epithelial mucin. In addition, prognosis of these patients with elevated serum KLβ6